Abstract:Cancer is an important factor affecting the quality of human life as well as causing death. Tumor ablation therapy is a minimally invasive local treatment modality with unique advantages in treating tumors that are difficult to remove surgically. However, due to its physical and chemical characteristics and the limitation of equipment technology, ablation therapy cannot completely kill all tumor tissues and cells at one time; moreover, it inevitably damages some normal tissues in the surrounding area during the ablation process. Therefore, this technology cannot be the first-line treatment for tumors at present. Metal nanoparticles themselves have good thermal and electrical conductivity and unique optical and magnetic properties. The combination of metal nanoparticles with tumor ablation technology, on the one hand, can enhance the killing and inhibiting effect of ablation technology on tumors by expanding the ablation range; on the other hand, the ablation technology changes the physicochemical microenvironment such as temperature, electric field, optics, oxygen content and pH in tumor tissues. It helps to stimulate the degree of local drug release of nanoparticles and increase the local content of anti-tumor drugs, thus forming a synergistic therapeutic effect with tumor ablation. Recent studies have found that some specific ablation methods will stimulate the body's immune response while physically killing tumor tissues, generating a large number of immune cells to cause secondary killing of tumor tissues and cells, and with the assistance of metal nanoparticles loaded with immune drugs, the effect of this anti-tumor immunotherapy can be further enhanced. Therefore, the combination of metal nanoparticles and ablative therapy has broad research potential. This review covers common metallic nanoparticles used for ablative therapy and discusses in detail their characteristics, mechanisms of action, potential challenges, and prospects in the field of ablation.

Immunostimulatory effects of thermal ablation: Challenges and future prospects

[Current Status and Progress of Thermal Ablation Combined with Immunotherapy for Lung Tumors]

Immunomodulatory effects of ablation therapy on tumors: Potentials for combination with immunotherapy

Tumor abolition and antitumor immunostimulation by physico-chemical tumor ablation

Progress in the cryoablation and cryoimmunotherapy for tumor

Research progress on anti-tumor immune effect of cryoablation

Research Advances of Anti-Tumor Immune Response Induced by Pulse Electric Field Ablation

Clinical application status and prospect of the combined anti-tumor strategy of ablation and immunotherapy

Potential of Thermal Ablation Combined with Immunotherapy in Peripheral Lung Tumors: A Review and Prospect

Thermal ablation in cancer

Nanoplatforms Potentiated Ablation-Immune Synergistic Therapy through Improving Local Control and Suppressing Recurrent Metastasis

Synergizing Thermal Ablation Modalities with Immunotherapy: Enough to Induce Systemic Antitumoral Immunity?

Immunomodulatory effects of microwave ablation on malignant tumors

Integrated omics characterization reveals reduced cancer indicators and elevated inflammatory factors after thermal ablation in non-small cell lung cancer patients

Tumor Thermal Ablation Enhancement by Micromaterials

Present and future of metal nanoparticles in tumor ablation therapy.

Immunological effect of local ablation combined with immunotherapy on solid malignancies

The CXCL10/CXCR3 Pathway Contributes to the Synergy of Thermal Ablation and PD-1 Blockade Therapy against Tumors

Modern cancer therapy: cryoablation meets immune checkpoint blockade

Thermal ablation enhances immunotherapeutic effect of IP-001 on orthotopic liver cancer in a rat model